Jeremy Bender Transaction History

Date Transaction Value Shares Traded Form
Jul 02 2024
SELL
Bona fide gift
-
241,912
Jul 02 2024
BUY
Bona fide gift
-
241,912
Jul 01 2023
SELL
Bona fide gift
-
329,963
Jul 01 2023
BUY
Other acquisition or disposition
-
240,288
Jul 01 2023
BUY
Bona fide gift
-
570,251

Also insider at

FUSN
Fusion Pharmaceuticals Inc. Healthcare
MREO
Mereo Biopharma Group plc Healthcare
JB

Jeremy Bender

CHIEF EXECUTIVE OFFICER
South San Francisco, CA

Track Institutional and Insider Activities on DAWN

Follow Day One Biopharmaceuticals, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells DAWN shares.

Notify only if
Any

Insider Trading

Get notified when an Day One Biopharmaceuticals, Inc. insider buys or sells DAWN shares.

Notify only if
Any
Any
P - Open market or private purchase×
S - Open market or private sale×
V - Transaction voluntarily reported earlier than required×
A - Grant, award, or other acquisition×
D - Sale (or disposition) back to the issuer×
F - Payment of exercise price or tax liability×
I - Discretionary transaction×
M - Exercise of conversion of derivative security×
C - Conversion of derivative security×
E - Expiration of short derivative position×
H - Expiration (or cancellation) of long derivative position with value received×
O - Exercise of out-of-the-money derivative securities×
X - Exercise of in-the-money or at-the-money derivatives securities×
G - Bona fide gift×
L - Small Acquisition×
W - Acquisition or disposition by will or laws×
Z - Deposit into or withdrawal from voting trust×
J - Other acquisition or disposition×
K - Transaction in equity swap or similar instrument×
U - Disposition due to a tender of shares in a change of control transaction×
20 item(s) selected

News

Receive news related to Day One Biopharmaceuticals, Inc.

Track Activities on DAWN